Fri 16'th Nov 2018
KalVista Pharmaceuticals Inc Stock Analysis
Technical stock analysis for Fri 16'th Nov 2018
KalVista Pharmaceuticals Inc gained 4.14% in the last trading day, rising from $18.10 to $18.85 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has fallen in 7 of the last 10 days and is down by -4.75% for this period. Volume fell in the last day by -39 039 shares, and in total, 70 823 shares bought and sold for approximately $1.34 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
KalVista Pharmaceuticals Inc lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.15% during the next 3 months and, with 90% probability hold a price between $19.34 and $27.56 at the end of this period.
A buy signal was issued from a pivot bottom point on Wednesday November 14, 2018, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. KalVista Pharmaceuticals Inc holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $19.15. On a fall, the stock will find some support from the short-term average at $18.19. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Relative Strength Index (RSI)
RSI14 is 52 and the stock is currently not being overbought or oversold
Support & Resistance
KalVista Pharmaceuticals Inc finds support from accumulated volume at $18.18.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $1.72 between high and low, or 9.81%. For the last week the stock has had a daily average volatility of 9.59%.
Our recommended stoploss: $18.09 (-4.03%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 2 days ago.)
Very Low Low Medium High Very High
KalVista Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development.
|KALV $18.85 $0.75(4.14%)|
KALV is up $0.75 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for KALV based on the 1-3 month system that more than doubles the S&P 500.
Click here – the KALV analysis is free »